TransMedics (TMDX) Change in Receivables (2018 - 2026)

TransMedics has reported Change in Receivables for 9 years, with the latest figure at $6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 85.23% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at -$51.6 million (down 185.89% YoY), and the FY2025 full-year result was -$14.0 million, down 140.66% from the prior year.
• Change in Receivables for Q1 2026 stood at $6.5 million, up from $3.6 million in the prior quarter.
• The five-year high for Change in Receivables was $44.1 million in Q1 2025, with the low at -$37.5 million in Q2 2025.
• Average Change in Receivables over 5 years is $4.8 million, with a median of $6.5 million recorded in 2026.
• Year-over-year, Change in Receivables soared 895.54% in 2022 and slumped 4856.14% in 2025.
• Tracing TMDX's Change in Receivables over 5 years: stood at $5.4 million in 2022, then tumbled by 47.71% to $2.8 million in 2023, then soared by 178.15% to $7.8 million in 2024, then tumbled by 54.32% to $3.6 million in 2025, then soared by 82.02% to $6.5 million in 2026.
• The last three Change in Receivables figures came in at $6.5 million (Q1 2026), $3.6 million (Q4 2025), and -$24.1 million (Q3 2025), per Business Quant data.

Peer Comparison